The value of algorithms predicting the Oncotype DX recurrence score should not be underestimated!
Breast Cancer Res Treat
.
2017 Jul;164(1):249-250.
doi: 10.1007/s10549-017-4236-2.
Epub 2017 Apr 13.
Authors
Bradley Turner
1
,
Ping Tang
2
,
David Hicks
2
Affiliations
1
University of Rochester Medical Center, Rochester, NY, USA. bradley_turner@urmc.rochester.edu.
2
University of Rochester Medical Center, Rochester, NY, USA.
PMID:
28409240
DOI:
10.1007/s10549-017-4236-2
No abstract available
Publication types
Letter
Comment
MeSH terms
Algorithms
Biomarkers, Tumor
Breast Neoplasms*
Gene Expression Profiling
Humans
Neoplasm Recurrence, Local*
Prognosis
Substances
Biomarkers, Tumor